Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95)

Immunology Letters

Volumn 116, Issue 2, 2008, Pages 211-217

  Hancz, Anikó ^a   Hérincs, Zoltán ^a   Neer, Zsuzsa ^a   Sármay, Gabriella ^a   Koncz, Gábor ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Apoptosis; B cell; BAFF; Fas; Selection; Signaling

Indexed keywords

B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; B LYMPHOCYTE RECEPTOR; FAS ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANTIGENS, CD95; APOPTOSIS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL LINE, TUMOR; HUMANS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION;

EID: 40149096635     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.12.009     Document Type: Article

References (41)

1. Bodmer J.L., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 27 (2002) 19-26
2. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293 (2001) 2108-2111
3. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 (2001) 2111-2114
4. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2 (2001) 638-643
5. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 97 (2000) 3370-3375
6. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 (1999) 1697-1710
7. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 (2002) 822-829
8. Mackay F., Schneider P., Rennert P., and Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21 (2003) 231-264
9. Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.S., Migone T.S., et al. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97 (2001) 198-204
10. Mackay F., Sierro F., Grey S.T., and Gordon T.P. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 8 (2005) 243-265
11. Schneider P., Mackay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189 (1999) 1747-1756
12. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 112 (2003) 286-297
13. Mecklenbrauker I., Kalled S.L., Leitges M., Mackay F., and Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature 431 (2004) 456-461
14. Craxton A., Draves K.E., Gruppi A., and Clark E.A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 202 (2005) 1363-1374
15. Claudio E., Brown K., and Siebenlist U. NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death Differ 13 (2006) 697-701
16. Sasaki Y., Derudder E., Hobeika E., Pelanda R., Reth M., Rajewsky K., et al. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24 (2006) 729-739
17. Enzler T., Bonizzi G., Silverman G.J., Otero D.C., Widhopf G.F., nzelon-Mills A., et al. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 25 (2006) 403-415
18. Endo T., Nishio M., Enzler T., Cottam H.B., Fukuda T., James D.F., et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 109 (2007) 703-710
19. Patke A., Mecklenbrauker I., Erdjument-Bromage H., Tempst P., and Tarakhovsky A. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 203 (2006) 2551-2562
20. Smith S.H., and Cancro M.P. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J Immunol 170 (2003) 5820-5823
21. Rothstein T.L. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res 10 (2000) 245-266
22. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., and Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356 (1992) 314-317
23. Defrance T., Casamayor-Palleja M., and Krammer P.H. The life and death of a B cell. Adv Cancer Res 86 (2002) 195-225
24. Tumang J.R., Negm R.S., Solt L.A., Schneider T.J., Colarusso T.P., Hastings W.D., et al. BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase. J Immunol 168 (2002) 2712-2719
25. Lee H.H., Dadgostar H., Cheng Q., Shu J., and Cheng G. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci USA 96 (1999) 9136-9141
26. Zazzeroni F., Papa S., geciras-Schimnich A., Alvarez K., Melis T., Bubici C., et al. Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis. Blood 102 (2003) 3270-3279
27. Benson R.J., Hostager B.S., and Bishop G.A. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K. Eur J Immunol 36 (2006) 2535-2543
28. Ho L., Davis R.E., Conne B., Chappuis R., Berczy M., Mhawech P., et al. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 105 (2005) 2891-2899
29. Hinshaw J.A., Mueller C.M., Scott D.W., and Williams M.S. B cell receptor signaling mediates immediate protection from Fas-induced apoptosis upstream of caspase activation through an atypical protein kinase C isozyme and de novo protein synthesis. Eur J Immunol 33 (2003) 2490-2500
30. Carey G.B., Donjerkovic D., Mueller C.M., Liu S., Hinshaw J.A., Tonnetti L., et al. B-cell receptor and Fas-mediated signals for life and death. Immunol Rev 176 (2000) 105-115
31. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374 (1995) 163-165
32. Koizumi T., Wang J., Suzuki Y., Masuda K., and Watanabe T. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4. Mol Immunol 33 (1996) 1247-1253
33. Darce J.R., Arendt B.K., Wu X., and Jelinek D.F. Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation. J Immunol 179 (2007) 7276-7286
34. Guzman-Rojas L., Sims-Mourtada J.C., Rangel R., and Martinez-Valdez H. Life and death within germinal centres: a double-edged sword. Immunology 107 (2002) 167-175
35. Mizuno T., Zhong X., and Rothstein T.L. Fas-induced apoptosis in B cells. Apoptosis 8 (2003) 451-460
36. Zhang X., Li L., Choe J., Krajewski S., Reed J.C., Thompson C., et al. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis. Cell Immunol 173 (1996) 149-154
37. Acosta-Rodriguez E.V., Craxton A., Hendricks D.W., Merino M.C., Montes C.L., Clark E.A., et al. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Eur J Immunol 37 (2007) 990-1000
38. Lavrik I.N., Golks A., Riess D., Bentele M., Eils R., and Krammer P.H. Analysis of CD95 threshold signaling: triggering of CD95(FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem 282 (2007) 13664-13671
39. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.O., Newell M.K., et al. The CD95 receptor: apoptosis revisited. Cell 129 (2007) 447-450
40. De C.G., Marcocci M.E., Torcia M., Lucibello M., Rosini P., Bonini P., et al. Bcl-2 Phosphorylation by p38 MAPK: identification of target sites and biologic consequences. J Biol Chem 281 (2006) 21353-21361
41. Farley N., Pedraza-Alva G., Serrano-Gomez D., Nagaleekar V., Aronshtam A., Krahl T., et al. p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells. Mol Cell Biol 26 (2006) 2118-2129